What is MedAvail Holdings, Inc. (MDVLQ) stock price today?

MedAvail Holdings, Inc. (MDVLQ) is currently trading at $0.00.

What is MDVLQ P/E ratio?

MedAvail Holdings, Inc.'s P/E ratio is -0.05. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is MDVLQ return on equity (ROE)?

MedAvail Holdings, Inc.'s return on equity (ROE) is -194.67%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is MedAvail Holdings, Inc.'s market cap?

MedAvail Holdings, Inc. has a market capitalization of $161.

OTC · Medical - Pharmaceuticals

MedAvail Holdings, Inc. (MDVLQ) Stock

$0.00 OTC: MDVLQ Healthcare

MedAvail Holdings, Inc. operated as a technology-driven provider of retail pharmacy services and solutions across the United States and Canada.

Valuation

Metric	Value
Price	$0.00
Market Cap	$161
P/E Ratio	-0.05
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$-35.56
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-194.67%
ROA	-68.15%
ROCE	-170.73%
Gross Margin	5.18%
Operating Margin	-106.98%
Net Margin	-106.16%
Debt/Equity	0.10
Current Ratio	6.51

Annual Financials (USD)

Metric	2018	2019	2020	2021	2022
Revenue	$0	$4.0M	$14.0M	$22.0M	$43.0M
Operating Profit	$-4.0M	$-21.0M	$-21.0M	$-44.0M	$-46.0M
Net Profit	$-3.0M	$-22.0M	$-27.0M	$-44.0M	$-48.0M
EPS	$-270.89	$-340.88	$-234.27	$-67.09	$-36.20
Op Margin	-1202.5%	-552.7%	-149.0%	-196.6%	-107.7%

Balance Sheet (USD)

Metric	2018	2019	2020	2021	2022
Total Assets	$4.0M	$18.0M	$69.0M	$38.0M	$33.0M
Total Liabilities	$2.0M	$115.0M	$8.0M	$19.0M	$12.0M
Cash	$0	$9.0M	$58.0M	$20.0M	$11.0M
Borrowings	$1.0M	$14.0M	$3.0M	$12.0M	$7.0M

Cash Flow (USD)

Metric	2018	2019	2020	2021	2022
Operating Cash Flow	$-3.0M	$-20.0M	$-29.0M	$-43.0M	$-48.0M
Investing Cash Flow	$0	$-1.0M	$-2.0M	$-7.0M	$-5.0M
Financing Cash Flow	$0	$0	$-5.0M	$-1.0M	$0
Net Cash Flow	$-1.0M	$5.0M	$49.0M	$-38.0M	$-8.0M
Free Cash Flow	$-3.0M	$-20.0M	$-29.0M	$-46.0M	$-50.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.03
FCF Yield	-1720.05%
Quick Ratio	2.86
Interest Coverage	-39.61
Return 1Y	0.00%
Return 3Y	-100.00%
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Institutional Holder	Shares	Report Date
Ameriflex Group, Inc.	124	2025-09-30

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BIOCQBiocept, Inc.	$0.00	—	-0.01	$263	0.00%
BSPMBiostar Pharmaceuticals, Inc.	$0.00	—	0.00	$264	0.00%
ELOXEloxx Pharmaceuticals, Inc.	$10.78	-9.72%	-2.05	$81.64M	0.00%
HLTHQCue Health Inc.	$0.00	—	0.00	$1591	0.00%
HTGMQHTG Molecular Diagnostics, Inc.	$0.00	—	0.00	$221	0.00%

About MedAvail Holdings, Inc.

MedAvail Holdings, Inc. operated as a technology-driven provider of retail pharmacy services and solutions across the United States and Canada. The company specialized in developing and bringing to market self-service pharmacy systems, mobile applications, and kiosk-based solutions. A primary offering was the MedAvail MedCenter, an advanced pharmacy technology designed to facilitate on-site prescription dispensing. This system allowed for direct medication access in various settings, including medical clinics, retail environments, and employer sites, utilizing an audio-visual link that provided real-time supervision and consultation from a licensed pharmacist during dispensing. The corporate headquarters for MedAvail Holdings, Inc. were situated in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc., along with its affiliated entities, submitted a voluntary petition for Chapter 7 liquidation to the U.S. Bankruptcy Court for the District of Delaware.

MedAvail Holdings, Inc. (MDVLQ) stock trades at $0.00 with a market capitalization of $161. The stock is valued at a price-to-earnings (P/E) ratio of -0.05, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, MedAvail Holdings, Inc. generates a return on equity (ROE) of -194.67%, return on capital employed of -170.73%, an operating margin of -106.98%, a net profit margin of -106.16%.

Official website: medavail.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides